MedPath

A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).

Phase 3
Completed
Conditions
Ocular Hypertension
Glaucoma
Interventions
Registration Number
NCT00383019
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Brief Summary

This study will examine the efficacy and safety of Xalacom comparing with those of Xalatan in Japanese patients with POAG or OH, in order to show superiority of Xalacom over Xalatan in efficacy and similarity of safety between Xalacom and Xalatan.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Intraocular pressure is 18 mmHg or more at baseline after treatment with Xalatan for 4 weeks or more.
Exclusion Criteria
  • History of no-response to timolol
  • History of trabeculectomy
  • History of other ocular surgery including ALT, SLT,and trabeculotomy within 6 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
XalatanXalatan-
XalacomXalacom-
Primary Outcome Measures
NameTimeMethod
Change of Intraocular Pressure (IOP) From Baseline to Week 8Baseline to Week 8

Value at Week 8 minus value at baseline

Secondary Outcome Measures
NameTimeMethod
Change of IOP From Baseline to Week 4Baseline to Week 4

Value at Week 4 minus value at baseline

Number of Subjects With an IOP of <=15 mmHg at Week 8Week 8

Number of subjects who achieved IOP reduction to 15 mmHg or below at Week 8

Number of Subjects With an IOP of <=16 mmHg at Week 8Week 8

Number of subjects who achieved IOP reduction to 16 mmHg or below at Week 8

Number of Subjects With an IOP Reduction of >=3 mmHg From Baseline to Week 8Baseline to Week 8

Number of subjects whose IOP were reduced by 3 mmHg or more at Week 8 from baseline

Percent Change of IOP From Baseline to Week 8Baseline to Week 8

Value at Week 8 minus value at baseline was divided by baseline value, then multiplied by 100

Number of Subjects With an IOP Reduction of >=2 mmHg From Baseline to Week 8Baseline to Week 8

Number of subjects whose IOP were reduced by 2 mmHg or more at Week 8 from baseline

Number of Subjects With an IOP of <=18 mmHg at Week 8Week 8

Number of subjects who achieved IOP reduction to 18 mmHg or below at Week 8

Number of Subjects With an IOP of <=17 mmHg at Week 8Week 8

Number of subjects who achieved IOP reduction to 17 mmHg or below at Week 8

Trial Locations

Locations (54)

Ohtsuka Eye Clinic

🇯🇵

Sapporo, Hokkaido, Japan

Kobe University Hospital

🇯🇵

Koube, Hyogo, Japan

Kanazawa university hospital

🇯🇵

Kanazawa, Ishikawa, Japan

Lumine Hatano Eye Clinic

🇯🇵

Fujisawa, Kanagawa, Japan

Fujita Eye Clinic

🇯🇵

Sapporo, Kokkaido, Japan

Chihara Eye Clinic

🇯🇵

Uji, Kyoto, Japan

Yoshimura Eye & Internal Medical Clinic

🇯🇵

Mishima, Shizuoka, Japan

Muramatsu Ganka Clinic

🇯🇵

Susono, Shizuoka, Japan

Miyazaki Eye Clinic

🇯🇵

Koto-ku, Tokyo, Japan

Kiyosenomori Hospital

🇯🇵

Kiyose, Tokyo, Japan

Shimizu Eye Clinic

🇯🇵

Musashino, Tokyo, Japan

WAKABA Eye Clinic

🇯🇵

Ota-ku, Tokyo, Japan

Seijo Clinic

🇯🇵

Setagaya, Tokyo, Japan

Yotsuya Shirato Ganka

🇯🇵

Shinjuku, Tokyo, Japan

Ueno Eye Clinic

🇯🇵

Taito-ku, Tokyo, Japan

Hayashi Eye Hospital

🇯🇵

Fujuoka, Japan

Hayashi Tennjin Eye Clinic

🇯🇵

Fukuoka, Japan

Gifu University Hospital

🇯🇵

Gifu, Japan

Kato Eye Clinic

🇯🇵

Fukuoka, Japan

Hiroshima University Hospital

🇯🇵

Hiroshima, Japan

Nishi Eye Hospital

🇯🇵

Osaka, Japan

Niigata University Medical and Dental Hospital

🇯🇵

Niigata, Japan

Osaka Welfare Pension Hospital

🇯🇵

Osaka, Japan

Sugita Eye Hospital

🇯🇵

Sugita, Japan

Nanba Opthalmology

🇯🇵

Shizuoka, Japan

Yasuma Eye Clinic

🇯🇵

Nagoya, Aichi, Japan

TANABE Eye Clinic

🇯🇵

Nagoya, Aichi, Japan

Mitsuhashi Eye Clinic

🇯🇵

Narashino, Chiba, Japan

Sasamoto Eye Clinic

🇯🇵

Sapporo, Hokkaido, Japan

Kaimeido Eye Clinic

🇯🇵

Sapporo, Hokkaido, Japan

Miyata Eye Hospital

🇯🇵

Miyakonojo, Miyazaki, Japan

Tachihi Bill clinic

🇯🇵

Tachikawa, Tokyo, Japan

Ochanomizu Inoue Eye Clinic

🇯🇵

Chiyoda-ku, Tokyo, Japan

Suzuki Eye Clinic

🇯🇵

Nagoya, Aichi, Japan

Ohyachi Kyouritsu Eye Clinic

🇯🇵

Sapporo, Hokkaido, Japan

Tanino clinic

🇯🇵

Kamakura, Kanagawa, Japan

Hanasaki Eye Clinic

🇯🇵

Fuji, Shizuoka, Japan

Tokyo Sugita Eye Center

🇯🇵

Katsushika-ku, Tokyo, Japan

Nomura Eye Clinic

🇯🇵

Ichinomiya, Aichi, Japan

Aoki eye clinic

🇯🇵

Sagamihara, Kanagawa, Japan

Hayashi Eye Clinic

🇯🇵

Kumagaya, Saitama, Japan

Nakajima Eye Clinic

🇯🇵

Fuji, Shizuoka, Japan

Manabe Clinic

🇯🇵

Hamura, Tokyo, Japan

Kikuna Yuda Eye Clinic

🇯🇵

Yokohama, Kanagawa, Japan

Hiraoka Eye Clinic

🇯🇵

Tokorozawa, Saitama, Japan

The University of Tokyo Hospital

🇯🇵

Bunkyo-ku, Tokyo, Japan

Tokyo Metropolitan Police Hospital

🇯🇵

Chiyoda, Tokyo, Japan

Keio Hachioji Matsumoto Eye Clinic

🇯🇵

Hachioji, Tokyo, Japan

Adachi Eye Clinic

🇯🇵

Osaka, Japan

Ohashi Eye Clinic

🇯🇵

Meguro-ku, Tokyo, Japan

Takase Ganka Tairamachi Clinic

🇯🇵

Meguro, Tokyo, Japan

Kunitoshi Eye Clinic

🇯🇵

Musashino, Tokyo, Japan

Ohshima Hospital of Opthalmology

🇯🇵

Fukuoka, Japan

Matsusura Eye Clinic

🇯🇵

Ichinomiya, Aichi, Japan

© Copyright 2025. All Rights Reserved by MedPath